Rationale and Design for a Multicenter, Phase II Study of Durvalumab Plus Concurrent Radiation Therapy in Locally Advanced Non-Small Cell Lung Cancer: The DOLPHIN Study (WJOG11619L)
Keyword(s):
Phase Ii
◽
2016 ◽
Vol 7
◽
pp. 11-16
◽